Daiichi Sankyo has taken a significant step toward expanding treatment options in Japan by submitting regulatory approval for Enhertu, an advanced cancer-fighting drug designed to
As reported by FiercePharma, the U.S. Food and Drug Administration has approved the first fully independent generic version of GlaxoSmithKline’s widely used asthma inhaler, Flovent,
You can not see, hear, or touch my rare condition. I STINK! (LITERALLY) I wasn’t sure if I was going to tell my story. But
Researchers have created a fundamentally new class of HIV-fighting molecules by combining two separate antiviral mechanisms into a single engineered protein. Early laboratory results, reported
As reported on BioPharmaDive, UCB has reported positive results from a head-to-head clinical trial showing that its anti-inflammatory biologic Bimzelx was more effective than AbbVie’s
Editor’s Note: Patient Worthy is proud and honored to share Jennifer’s story with cystic fibrosis and colon cancer, originally published on the Cystic Fibrosis Research
The biotechnology sector experienced significant positive developments this week, with Xenon Pharmaceuticals’ seizure medication achieving a decisive late-stage victory while regulatory pathways accelerated for several
As reported on Healio, glucagon-like peptide-1 (GLP-1) receptor agonists, best known for treating diabetes and obesity, are emerging as unexpected players in breast cancer care.
CAR T- cells are immune cells that are engineered in a laboratory to attack cancer. The therapy has worked as planned for certain blood cancers
Artios Pharma has achieved a significant milestone in cancer treatment development with the U.S. Food and Drug Administration’s granting of Fast Track designation to ART6043,
As reported on drugs.com, Bristol Myers Squibb (BMS) has announced encouraging interim results from the Phase 3 portion of the SUCCESSOR-2 clinical trial evaluating oral
As reported on FierceBioTech, the U.S. Food and Drug Administration has released its complete response letter (CRL) detailing why it declined to approve Regenxbio’s experimental
As covered on PharmaBiz, Roche has reported topline results from the phase III persevERA Breast Cancer study, which evaluated the oral selective oestrogen receptor degrader
Editor’s Note: Patient Worthy is proud to share this article from our friends at the Courageous Parents Network. A parent often can sense when there
Daiichi Sankyo has taken a significant step forward in expanding treatment options for early-stage breast cancer patients by submitting a supplemental New Drug Application (sNDA)
As reported in a recent article by Pharmaceutical Technology, Bristol Myers Squibb (BMS) has secured US Food and Drug Administration (FDA) approval for Sotyktu (deucravacitinib)
Editor’s Note: Patient Worthy is honored to share this caregiver story with you, originally written by Aisling Melton, Parent Champion at Courageous Parents Network. In
GlaxoSmithKline has achieved a significant regulatory milestone as China’s National Medical Products Administration granted priority review status to linerixibat, an investigational treatment for cholestatic pruritus
Remix Therapeutics Advances Breakthrough Cancer Therapy with FDA Fast Track Designation for REM-422 bit.ly/3NraASF Read now at PatientWorthy.com
#PatientWorthy #FDAFastTrack #adenoidcysticcarcinoma #ACC REM-422
Narcolepsy is more than just “feeling tired”—it’s a neurological condition that disrupts the brain’s ability to regulate sleep and wakefulness. People living with narcolepsy may experience excessive daytime sleepiness, sudden sleep attacks, sleep paralysis, vivid hallucinations, and in some cases cataplexy (a sudden loss of muscle control triggered by strong emotions).
While the exact cause isn’t always clear, narcolepsy is often linked to a deficiency of hypocretin (a brain chemical that helps control alertness), and may involve genetic and autoimmune factors. Certain risk factors—like family history or brain injury—can increase susceptibility, while triggers such as stress, lack of sleep, illness, or major life changes can worsen symptoms.
Understanding narcolepsy helps break stigma and encourages earlier diagnosis, better management, and stronger support for those affected. Awareness isn’t just knowledge—it’s empathy in action.
#NarcolepsyAwareness #SleepDisorder #InvisibleIllness #PatientWorthy
April is Stress Awareness Month 💙
Stress looks different for everyone, and so does healing. Small steps, taken consistently, can make a meaningful difference.
Let’s check in on ourselves and each other, reduce stigma, and prioritize wellbeing—this month and beyond.
#StressAwarenessMonth #MentalHealthMatters #SelfCare #PatientWorthy
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
